Merck EVP DeLuca sells $5.9m in stock

Richard DeLuca, Executive Vice President and President of Merck Animal Health, sold approximately $5.9 million worth of Merck & Co., Inc. (MRK) common stock across three days between August 10 and August 12, 2026. The executive sold a total of 45,320 shares, with transactions ranging from $130.4345 to $132.3496 per share. On August 10, DeLuca sold 20,784 shares at an average price of $130.4345, followed by two separate sales on August 11 of 7,410 and 5,427 shares at average prices of $131.3313 and $132.3496, respectively.

Finally, on August 12, he sold 11,099 shares at an average price of $131.6128, along with a smaller transaction of 600 shares at an average price of $132.0367. Today, DeLuca directly owns 110,167.07 shares of Merck & Co., Inc. common stock. In recent news, Merck reported second-quarter 2026 earnings that surpassed market expectations, with revenue reaching $16.6 billion, exceeding the forecast of $16.41 billion.

The company's performance was driven by strong sales in oncology, vaccines, and newer products, resulting in Merck raising and narrowing its full-year outlook.